Guardant Health partners with Nuvalent for cancer diagnostics development
Go back to Guardant Health partners with Nuvalent for cancer diagnostics development| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 151.37 +2.15 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.22 | 52 Week High | $5.84 | |||
| Open | $150.00 | 52 Week Low | $5.49 | |||
| Day High | $153.00 | P/E | N/A | |||
| Day Low | $148.46 | EPS | $0.00 | |||
| Volume | 1,079,797 | |||||
| Nuvel Holdings, Inc. (NASDAQ: NUVL) | Delayed: 123.48 -0.04 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.52 | 52 Week High | $0.40 | |||
| Open | $123.56 | 52 Week Low | $0.14 | |||
| Day High | $123.58 | P/E | N/A | |||
| Day Low | $123.46 | EPS | $-0.56 | |||
| Volume | 726,969 | |||||
